The use of guselkumab 100 mg every 4 weeks on patients with hidradenitis suppurativa and a literature review

The use of guselkumab 100 mg every 4 weeks on patients with hidradenitis suppurativa and a literature review

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dermatologic therapy 2020-05, Vol.33 (3), p.e13456-n/a
Hauptverfasser: Montero‐Vilchez, Trinidad, Martinez‐Lopez, Antonio, Salvador‐Rodriguez, Luis, Arias‐Santiago, Salvador, Molina‐Leyva, Alejandro
Format: Artikel
Sprache:eng
Schlagworte:
Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal, Humanized
Hidradenitis Suppurativa - diagnosis
Hidradenitis Suppurativa - drug therapy
Humans
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 3
container_start_page e13456
container_title Dermatologic therapy
container_volume 33
creator Montero‐Vilchez, Trinidad
Martinez‐Lopez, Antonio
Salvador‐Rodriguez, Luis
Arias‐Santiago, Salvador
Molina‐Leyva, Alejandro
description
doi_str_mv 10.1111/dth.13456
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2393574580</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2393574580</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3606-f5401ef8c344bce08d37fd1e927b875006e2d0fbc812fcc6d499dbf0e5d39acb3</originalsourceid><addsrcrecordid>eNp1kLlOAzEURS0EghAo-AHkEopJvMzmErEFCYkm1COP_ZyYzIY9kygdLb_Jl2AI0PGatx2d4iJ0RsmEhprqfjmhPE7SPTSiCRNRTqjYDzMXaUSYSI_QsfcvhFAmOD1ER5xxKmjGRqibLwEPHnBr8CL0ajXUssSUkI-393qBYQ1ui-OwbABWHrcN7mRvoek93th-iZdWO6mhsb312A9dN7jwX0ssG40lrmwP4TA4wA7WFjYn6MDIysPpTx-j57vb-fUseny6f7i-eowUT0kamSQmFEyueByXCkiueWY0BcGyMs8SQlJgmphS5ZQZpVIdC6FLQyDRXEhV8jG62Hk7174O4Puitl5BVckG2sEXjAueZHGSk4Be7lDlWu8dmKJztpZuW1BSfAVchICL74ADe_6jHcoa9B_5m2gApjtgYyvY_m8qbuaznfITrOiIJw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2393574580</pqid></control><display><type>article</type><title>The use of guselkumab 100 mg every 4 weeks on patients with hidradenitis suppurativa and a literature review</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Montero‐Vilchez, Trinidad ; Martinez‐Lopez, Antonio ; Salvador‐Rodriguez, Luis ; Arias‐Santiago, Salvador ; Molina‐Leyva, Alejandro</creator><creatorcontrib>Montero‐Vilchez, Trinidad ; Martinez‐Lopez, Antonio ; Salvador‐Rodriguez, Luis ; Arias‐Santiago, Salvador ; Molina‐Leyva, Alejandro</creatorcontrib><identifier>ISSN: 1396-0296</identifier><identifier>EISSN: 1529-8019</identifier><identifier>DOI: 10.1111/dth.13456</identifier><identifier>PMID: 32319172</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Antibodies, Monoclonal - adverse effects ; Antibodies, Monoclonal, Humanized ; Hidradenitis Suppurativa - diagnosis ; Hidradenitis Suppurativa - drug therapy ; Humans</subject><ispartof>Dermatologic therapy, 2020-05, Vol.33 (3), p.e13456-n/a</ispartof><rights>2020 Wiley Periodicals LLC.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3606-f5401ef8c344bce08d37fd1e927b875006e2d0fbc812fcc6d499dbf0e5d39acb3</citedby><cites>FETCH-LOGICAL-c3606-f5401ef8c344bce08d37fd1e927b875006e2d0fbc812fcc6d499dbf0e5d39acb3</cites><orcidid>0000-0003-4035-7955 ; 0000-0001-6882-2113 ; 0000-0003-0304-7317</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fdth.13456$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fdth.13456$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32319172$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Montero‐Vilchez, Trinidad</creatorcontrib><creatorcontrib>Martinez‐Lopez, Antonio</creatorcontrib><creatorcontrib>Salvador‐Rodriguez, Luis</creatorcontrib><creatorcontrib>Arias‐Santiago, Salvador</creatorcontrib><creatorcontrib>Molina‐Leyva, Alejandro</creatorcontrib><title>The use of guselkumab 100 mg every 4 weeks on patients with hidradenitis suppurativa and a literature review</title><title>Dermatologic therapy</title><addtitle>Dermatol Ther</addtitle><subject>Antibodies, Monoclonal - adverse effects</subject><subject>Antibodies, Monoclonal, Humanized</subject><subject>Hidradenitis Suppurativa - diagnosis</subject><subject>Hidradenitis Suppurativa - drug therapy</subject><subject>Humans</subject><issn>1396-0296</issn><issn>1529-8019</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kLlOAzEURS0EghAo-AHkEopJvMzmErEFCYkm1COP_ZyYzIY9kygdLb_Jl2AI0PGatx2d4iJ0RsmEhprqfjmhPE7SPTSiCRNRTqjYDzMXaUSYSI_QsfcvhFAmOD1ER5xxKmjGRqibLwEPHnBr8CL0ajXUssSUkI-393qBYQ1ui-OwbABWHrcN7mRvoek93th-iZdWO6mhsb312A9dN7jwX0ssG40lrmwP4TA4wA7WFjYn6MDIysPpTx-j57vb-fUseny6f7i-eowUT0kamSQmFEyueByXCkiueWY0BcGyMs8SQlJgmphS5ZQZpVIdC6FLQyDRXEhV8jG62Hk7174O4Puitl5BVckG2sEXjAueZHGSk4Be7lDlWu8dmKJztpZuW1BSfAVchICL74ADe_6jHcoa9B_5m2gApjtgYyvY_m8qbuaznfITrOiIJw</recordid><startdate>202005</startdate><enddate>202005</enddate><creator>Montero‐Vilchez, Trinidad</creator><creator>Martinez‐Lopez, Antonio</creator><creator>Salvador‐Rodriguez, Luis</creator><creator>Arias‐Santiago, Salvador</creator><creator>Molina‐Leyva, Alejandro</creator><general>John Wiley &amp; Sons, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4035-7955</orcidid><orcidid>https://orcid.org/0000-0001-6882-2113</orcidid><orcidid>https://orcid.org/0000-0003-0304-7317</orcidid></search><sort><creationdate>202005</creationdate><title>The use of guselkumab 100 mg every 4 weeks on patients with hidradenitis suppurativa and a literature review</title><author>Montero‐Vilchez, Trinidad ; Martinez‐Lopez, Antonio ; Salvador‐Rodriguez, Luis ; Arias‐Santiago, Salvador ; Molina‐Leyva, Alejandro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3606-f5401ef8c344bce08d37fd1e927b875006e2d0fbc812fcc6d499dbf0e5d39acb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antibodies, Monoclonal - adverse effects</topic><topic>Antibodies, Monoclonal, Humanized</topic><topic>Hidradenitis Suppurativa - diagnosis</topic><topic>Hidradenitis Suppurativa - drug therapy</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Montero‐Vilchez, Trinidad</creatorcontrib><creatorcontrib>Martinez‐Lopez, Antonio</creatorcontrib><creatorcontrib>Salvador‐Rodriguez, Luis</creatorcontrib><creatorcontrib>Arias‐Santiago, Salvador</creatorcontrib><creatorcontrib>Molina‐Leyva, Alejandro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Dermatologic therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Montero‐Vilchez, Trinidad</au><au>Martinez‐Lopez, Antonio</au><au>Salvador‐Rodriguez, Luis</au><au>Arias‐Santiago, Salvador</au><au>Molina‐Leyva, Alejandro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The use of guselkumab 100 mg every 4 weeks on patients with hidradenitis suppurativa and a literature review</atitle><jtitle>Dermatologic therapy</jtitle><addtitle>Dermatol Ther</addtitle><date>2020-05</date><risdate>2020</risdate><volume>33</volume><issue>3</issue><spage>e13456</spage><epage>n/a</epage><pages>e13456-n/a</pages><issn>1396-0296</issn><eissn>1529-8019</eissn><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>32319172</pmid><doi>10.1111/dth.13456</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-4035-7955</orcidid><orcidid>https://orcid.org/0000-0001-6882-2113</orcidid><orcidid>https://orcid.org/0000-0003-0304-7317</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1396-0296
ispartof Dermatologic therapy, 2020-05, Vol.33 (3), p.e13456-n/a
issn 1396-0296
1529-8019
language eng
recordid cdi_proquest_miscellaneous_2393574580
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Antibodies, Monoclonal - adverse effects
Antibodies, Monoclonal, Humanized
Hidradenitis Suppurativa - diagnosis
Hidradenitis Suppurativa - drug therapy
Humans
title The use of guselkumab 100 mg every 4 weeks on patients with hidradenitis suppurativa and a literature review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T12%3A36%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20use%20of%20guselkumab%20100%E2%80%89mg%20every%204%E2%80%89weeks%20on%20patients%20with%20hidradenitis%20suppurativa%20and%20a%20literature%20review&rft.jtitle=Dermatologic%20therapy&rft.au=Montero%E2%80%90Vilchez,%20Trinidad&rft.date=2020-05&rft.volume=33&rft.issue=3&rft.spage=e13456&rft.epage=n/a&rft.pages=e13456-n/a&rft.issn=1396-0296&rft.eissn=1529-8019&rft_id=info:doi/10.1111/dth.13456&rft_dat=%3Cproquest_cross%3E2393574580%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2393574580&rft_id=info:pmid/32319172&rfr_iscdi=true